Trial Profile
An Open-Label Single-Dose And Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of Oxymorphone Hydrochloride (HCl) For Acute Moderate To Severe Postoperative Pain In Pediatric Subjects
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 28 Oct 2021
Price :
$35
*
At a glance
- Drugs Oxymorphone (Primary) ; Oxymorphone (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 26 Jan 2021 Status changed from suspended to discontinued.
- 19 Jul 2019 Status changed from recruiting to suspended.
- 17 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2020.